H. pylori infection and GI disease: what critical care physicians need to know. Who should be tested for H. pylori? When is treatment needed?
Helicobacter (Campylobacter) pylori infection has emerged as a major cause of gastritis, peptic ulcers, and gastric malignancies. Not all patients with H. pylori infection require treatment; however, for those with ulcer disease (particularly those with bleeding), antibiotic therapy can be curative. To confirm infection (or its eradication), use the rapid urease assay, serologic examination or, when available, the urea breath test. Treatment options include triple therapy (with bismuth subsalicylate, metronidazole, and either tetracycline or amoxicillin) and dual therapy (with omeprazole and either amoxicillin or clarithromycin). For patients with an active ulcer, follow antibiotic therapy with ranitidine or omeprazole.
Duckworth
C
C
University of Virginia Health Sciences Center, Charlottesville, USA.
Peura
D A
DA
D000900:Anti-Bacterial Agents; D003422:Critical Care; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology*; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy / Q000382:microbiology*; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000382:microbiology*